Kiro
Kiro is the first AI-powered digital health platform for clinical biology in Europe. The company uses medical-grade artificial intelligence and cloud technology to leverage laboratory results and bring better outcomes for patients. Developed in partnership with leading laboratories, hospitals and physicians, and already used by millions, Kiro’s solutions provide personalized and easy-to-understand results for patients and caregivers while helping healthcare providers improve treatment for patients with real-time clinical decision support tools.
Sector
Digital Medicine
Location
Paris
Strategies
Digital Medicine
Status
Live
Website
www.kiro.bio
SofinnovaCapital
The Sofinnova Capital Strategy is our flagship fund, investing as founding or lead investor in early-stage biopharma and medtech start-ups developing groundbreaking therapeutic technologies.
SofinnovaMD Start
The Sofinnova MD Start Strategy is our in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy invests in growth-stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy invests in early-stage sustainable companies across the agriculture, chemicals, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy makes early-stage investments in leading Italian science for the benefit of patients around the world.
SofinnovaDigital Medicine
Our Digital Medicine Strategy backs early-stage techbio and healthtech start-ups at the intersection of biology, data, and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is our biotech accelerator, partnering with leading research organizations to create and build European biotech start-ups.